REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs | MicrobiomeTrials← Back to trialsNCT05622721
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-05-30Est. Completion: 2026-09-01
Enrollment target: 200 participants Locations- The Robert Schattner Center, University of Pennsylvania, School of Dental Medicine, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
End-stage Renal Disease (ESRD)Kidney Transplantation
Chronic kidney disease affects approximately 10% of the world population. End-stage renal disease (ESRD) is associated w…
Lyon, FranceEst. completion Oct 15, 2028
Severe Traumatic Brain Injury
Severe traumatic brain injury (sTBI) is a devastating condition with no targeted therapies available to prevent secondar…
Grand Rapids, United StatesEst. completion Jul 1, 2028
Endometriosis
Microbiome Dysbiosis
Gastrointestinal Symptoms
This study is a double-blind, randomized, placebo-controlled study that evaluates the safety and tolerability of a fiber…
San Francisco, United StatesEst. completion Jun 2027